nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—SRMS—telencephalon—Alzheimer's disease	0.00203	0.00929	CbGeAlD
Dasatinib—EPHA2—blood vessel—Alzheimer's disease	0.00202	0.00924	CbGeAlD
Dasatinib—STAT5B—telencephalon—Alzheimer's disease	0.00188	0.00861	CbGeAlD
Dasatinib—SIK3—forebrain—Alzheimer's disease	0.00184	0.00842	CbGeAlD
Dasatinib—SRC—blood vessel—Alzheimer's disease	0.00175	0.00801	CbGeAlD
Dasatinib—MYT1—brain—Alzheimer's disease	0.00171	0.00782	CbGeAlD
Dasatinib—SIK3—telencephalon—Alzheimer's disease	0.00169	0.00774	CbGeAlD
Dasatinib—EPHB3—embryo—Alzheimer's disease	0.00168	0.0077	CbGeAlD
Dasatinib—EPHA5—forebrain—Alzheimer's disease	0.00168	0.00766	CbGeAlD
Dasatinib—TNK2—forebrain—Alzheimer's disease	0.00161	0.00736	CbGeAlD
Dasatinib—CSK—embryo—Alzheimer's disease	0.00157	0.00716	CbGeAlD
Dasatinib—EPHA5—telencephalon—Alzheimer's disease	0.00154	0.00704	CbGeAlD
Dasatinib—EPHB1—nervous system—Alzheimer's disease	0.00149	0.00682	CbGeAlD
Dasatinib—EPHB3—forebrain—Alzheimer's disease	0.00149	0.00681	CbGeAlD
Dasatinib—TNK2—telencephalon—Alzheimer's disease	0.00148	0.00676	CbGeAlD
Dasatinib—EPHB1—central nervous system—Alzheimer's disease	0.00144	0.00657	CbGeAlD
Dasatinib—KIT—blood vessel—Alzheimer's disease	0.00143	0.00653	CbGeAlD
Dasatinib—EPHA4—embryo—Alzheimer's disease	0.00141	0.00643	CbGeAlD
Dasatinib—EPHB1—cerebellum—Alzheimer's disease	0.00141	0.00642	CbGeAlD
Dasatinib—PDGFRB—blood vessel—Alzheimer's disease	0.0014	0.00638	CbGeAlD
Dasatinib—ERBB3—embryo—Alzheimer's disease	0.00139	0.00636	CbGeAlD
Dasatinib—EPHB3—telencephalon—Alzheimer's disease	0.00137	0.00626	CbGeAlD
Dasatinib—HCK—forebrain—Alzheimer's disease	0.00137	0.00625	CbGeAlD
Dasatinib—SIK2—nervous system—Alzheimer's disease	0.00132	0.00603	CbGeAlD
Dasatinib—MAPK14—embryo—Alzheimer's disease	0.0013	0.00593	CbGeAlD
Dasatinib—FGR—embryo—Alzheimer's disease	0.00129	0.0059	CbGeAlD
Dasatinib—PKMYT1—nervous system—Alzheimer's disease	0.00129	0.00587	CbGeAlD
Dasatinib—SIK2—central nervous system—Alzheimer's disease	0.00127	0.0058	CbGeAlD
Dasatinib—HCK—telencephalon—Alzheimer's disease	0.00126	0.00575	CbGeAlD
Dasatinib—SIK1—forebrain—Alzheimer's disease	0.00126	0.00574	CbGeAlD
Dasatinib—EPHA4—forebrain—Alzheimer's disease	0.00124	0.00568	CbGeAlD
Dasatinib—PKMYT1—central nervous system—Alzheimer's disease	0.00124	0.00566	CbGeAlD
Dasatinib—ERBB3—forebrain—Alzheimer's disease	0.00123	0.00563	CbGeAlD
Dasatinib—EPHB2—nervous system—Alzheimer's disease	0.00123	0.0056	CbGeAlD
Dasatinib—JAK2—embryo—Alzheimer's disease	0.00122	0.00558	CbGeAlD
Dasatinib—PKMYT1—cerebellum—Alzheimer's disease	0.00121	0.00553	CbGeAlD
Dasatinib—FYN—embryo—Alzheimer's disease	0.0012	0.0055	CbGeAlD
Dasatinib—SRMS—nervous system—Alzheimer's disease	0.0012	0.00548	CbGeAlD
Dasatinib—EPHB2—central nervous system—Alzheimer's disease	0.00118	0.0054	CbGeAlD
Dasatinib—EPHA8—nervous system—Alzheimer's disease	0.00118	0.00537	CbGeAlD
Dasatinib—SIK1—telencephalon—Alzheimer's disease	0.00116	0.00528	CbGeAlD
Dasatinib—SRMS—central nervous system—Alzheimer's disease	0.00116	0.00528	CbGeAlD
Dasatinib—MAPK14—forebrain—Alzheimer's disease	0.00115	0.00524	CbGeAlD
Dasatinib—EPHA4—telencephalon—Alzheimer's disease	0.00114	0.00523	CbGeAlD
Dasatinib—EPHB1—brain—Alzheimer's disease	0.00114	0.00522	CbGeAlD
Dasatinib—ERBB3—telencephalon—Alzheimer's disease	0.00113	0.00518	CbGeAlD
Dasatinib—EPHA8—central nervous system—Alzheimer's disease	0.00113	0.00517	CbGeAlD
Dasatinib—MAP3K2—telencephalon—Alzheimer's disease	0.00112	0.00513	CbGeAlD
Dasatinib—STAT5B—nervous system—Alzheimer's disease	0.00111	0.00508	CbGeAlD
Dasatinib—EPHA8—cerebellum—Alzheimer's disease	0.00111	0.00506	CbGeAlD
Dasatinib—JAK2—forebrain—Alzheimer's disease	0.00108	0.00493	CbGeAlD
Dasatinib—STAT5B—central nervous system—Alzheimer's disease	0.00107	0.00489	CbGeAlD
Dasatinib—PDGFRA—embryo—Alzheimer's disease	0.00107	0.00487	CbGeAlD
Dasatinib—FYN—forebrain—Alzheimer's disease	0.00107	0.00487	CbGeAlD
Dasatinib—MAPK14—telencephalon—Alzheimer's disease	0.00106	0.00482	CbGeAlD
Dasatinib—STAT5B—cerebellum—Alzheimer's disease	0.00105	0.00478	CbGeAlD
Dasatinib—SRC—embryo—Alzheimer's disease	0.00105	0.00478	CbGeAlD
Dasatinib—MAP4K5—forebrain—Alzheimer's disease	0.00104	0.00476	CbGeAlD
Dasatinib—EPHA3—nervous system—Alzheimer's disease	0.00103	0.0047	CbGeAlD
Dasatinib—SIK2—brain—Alzheimer's disease	0.00101	0.00461	CbGeAlD
Dasatinib—EPHB4—telencephalon—Alzheimer's disease	0.001	0.00457	CbGeAlD
Dasatinib—SIK3—nervous system—Alzheimer's disease	0.001	0.00457	CbGeAlD
Dasatinib—EPHB6—forebrain—Alzheimer's disease	0.000995	0.00454	CbGeAlD
Dasatinib—JAK2—telencephalon—Alzheimer's disease	0.000993	0.00454	CbGeAlD
Dasatinib—EPHA3—central nervous system—Alzheimer's disease	0.00099	0.00452	CbGeAlD
Dasatinib—PKMYT1—brain—Alzheimer's disease	0.000983	0.00449	CbGeAlD
Dasatinib—FYN—telencephalon—Alzheimer's disease	0.00098	0.00447	CbGeAlD
Dasatinib—SIK3—central nervous system—Alzheimer's disease	0.000963	0.0044	CbGeAlD
Dasatinib—MAP4K5—telencephalon—Alzheimer's disease	0.000957	0.00437	CbGeAlD
Dasatinib—PDGFRA—forebrain—Alzheimer's disease	0.000943	0.00431	CbGeAlD
Dasatinib—SIK3—cerebellum—Alzheimer's disease	0.000941	0.0043	CbGeAlD
Dasatinib—CSF1R—embryo—Alzheimer's disease	0.000939	0.00429	CbGeAlD
Dasatinib—EPHB2—brain—Alzheimer's disease	0.000938	0.00428	CbGeAlD
Dasatinib—ZAK—nervous system—Alzheimer's disease	0.00093	0.00425	CbGeAlD
Dasatinib—SRC—forebrain—Alzheimer's disease	0.000925	0.00422	CbGeAlD
Dasatinib—SRMS—brain—Alzheimer's disease	0.000918	0.00419	CbGeAlD
Dasatinib—EPHB6—telencephalon—Alzheimer's disease	0.000915	0.00418	CbGeAlD
Dasatinib—EPHA5—nervous system—Alzheimer's disease	0.00091	0.00416	CbGeAlD
Dasatinib—LYN—nervous system—Alzheimer's disease	0.000905	0.00413	CbGeAlD
Dasatinib—EPHA8—brain—Alzheimer's disease	0.000899	0.00411	CbGeAlD
Dasatinib—ZAK—central nervous system—Alzheimer's disease	0.000895	0.00409	CbGeAlD
Dasatinib—BMPR1B—nervous system—Alzheimer's disease	0.000892	0.00407	CbGeAlD
Dasatinib—MAP3K19—nervous system—Alzheimer's disease	0.000892	0.00407	CbGeAlD
Dasatinib—YES1—telencephalon—Alzheimer's disease	0.000884	0.00404	CbGeAlD
Dasatinib—EPHA5—central nervous system—Alzheimer's disease	0.000876	0.004	CbGeAlD
Dasatinib—ZAK—cerebellum—Alzheimer's disease	0.000875	0.004	CbGeAlD
Dasatinib—TNK2—nervous system—Alzheimer's disease	0.000874	0.00399	CbGeAlD
Dasatinib—LYN—central nervous system—Alzheimer's disease	0.000872	0.00398	CbGeAlD
Dasatinib—PDGFRA—telencephalon—Alzheimer's disease	0.000867	0.00396	CbGeAlD
Dasatinib—MAP3K19—central nervous system—Alzheimer's disease	0.000858	0.00392	CbGeAlD
Dasatinib—BMPR1B—central nervous system—Alzheimer's disease	0.000858	0.00392	CbGeAlD
Dasatinib—EPHA5—cerebellum—Alzheimer's disease	0.000856	0.00391	CbGeAlD
Dasatinib—KIT—embryo—Alzheimer's disease	0.000853	0.00389	CbGeAlD
Dasatinib—SRC—telencephalon—Alzheimer's disease	0.000851	0.00388	CbGeAlD
Dasatinib—STAT5B—brain—Alzheimer's disease	0.00085	0.00388	CbGeAlD
Dasatinib—TNK2—central nervous system—Alzheimer's disease	0.000842	0.00384	CbGeAlD
Dasatinib—BMPR1B—cerebellum—Alzheimer's disease	0.000839	0.00383	CbGeAlD
Dasatinib—PDGFRB—embryo—Alzheimer's disease	0.000833	0.0038	CbGeAlD
Dasatinib—CSF1R—forebrain—Alzheimer's disease	0.00083	0.00379	CbGeAlD
Dasatinib—TNK2—cerebellum—Alzheimer's disease	0.000823	0.00376	CbGeAlD
Dasatinib—TESK1—nervous system—Alzheimer's disease	0.000822	0.00375	CbGeAlD
Dasatinib—STK36—nervous system—Alzheimer's disease	0.000809	0.00369	CbGeAlD
Dasatinib—EPHB3—nervous system—Alzheimer's disease	0.000809	0.00369	CbGeAlD
Dasatinib—TESK1—central nervous system—Alzheimer's disease	0.000791	0.00361	CbGeAlD
Dasatinib—EPHA3—brain—Alzheimer's disease	0.000786	0.00359	CbGeAlD
Dasatinib—MAP2K5—telencephalon—Alzheimer's disease	0.000782	0.00357	CbGeAlD
Dasatinib—LIMK2—nervous system—Alzheimer's disease	0.000782	0.00357	CbGeAlD
Dasatinib—STK36—central nervous system—Alzheimer's disease	0.000779	0.00356	CbGeAlD
Dasatinib—EPHB3—central nervous system—Alzheimer's disease	0.000779	0.00356	CbGeAlD
Dasatinib—TESK1—cerebellum—Alzheimer's disease	0.000774	0.00353	CbGeAlD
Dasatinib—SIK3—brain—Alzheimer's disease	0.000765	0.00349	CbGeAlD
Dasatinib—CSF1R—telencephalon—Alzheimer's disease	0.000764	0.00349	CbGeAlD
Dasatinib—STK36—cerebellum—Alzheimer's disease	0.000761	0.00348	CbGeAlD
Dasatinib—EPHB3—cerebellum—Alzheimer's disease	0.000761	0.00348	CbGeAlD
Dasatinib—STK35—nervous system—Alzheimer's disease	0.000758	0.00346	CbGeAlD
Dasatinib—CSK—nervous system—Alzheimer's disease	0.000753	0.00344	CbGeAlD
Dasatinib—LIMK2—central nervous system—Alzheimer's disease	0.000753	0.00344	CbGeAlD
Dasatinib—HCK—nervous system—Alzheimer's disease	0.000743	0.0034	CbGeAlD
Dasatinib—ABL1—embryo—Alzheimer's disease	0.000742	0.00339	CbGeAlD
Dasatinib—LIMK2—cerebellum—Alzheimer's disease	0.000736	0.00336	CbGeAlD
Dasatinib—STK35—central nervous system—Alzheimer's disease	0.00073	0.00333	CbGeAlD
Dasatinib—CSK—central nervous system—Alzheimer's disease	0.000725	0.00331	CbGeAlD
Dasatinib—HCK—central nervous system—Alzheimer's disease	0.000716	0.00327	CbGeAlD
Dasatinib—STK35—cerebellum—Alzheimer's disease	0.000713	0.00326	CbGeAlD
Dasatinib—ZAK—brain—Alzheimer's disease	0.000711	0.00325	CbGeAlD
Dasatinib—CSK—cerebellum—Alzheimer's disease	0.000709	0.00324	CbGeAlD
Dasatinib—EPHA5—brain—Alzheimer's disease	0.000696	0.00318	CbGeAlD
Dasatinib—ABL2—cerebellum—Alzheimer's disease	0.000695	0.00318	CbGeAlD
Dasatinib—KIT—telencephalon—Alzheimer's disease	0.000693	0.00317	CbGeAlD
Dasatinib—LYN—brain—Alzheimer's disease	0.000692	0.00316	CbGeAlD
Dasatinib—SIK1—nervous system—Alzheimer's disease	0.000683	0.00312	CbGeAlD
Dasatinib—BMPR1B—brain—Alzheimer's disease	0.000681	0.00311	CbGeAlD
Dasatinib—MAP3K19—brain—Alzheimer's disease	0.000681	0.00311	CbGeAlD
Dasatinib—BTK—brain—Alzheimer's disease	0.000678	0.0031	CbGeAlD
Dasatinib—PDGFRB—telencephalon—Alzheimer's disease	0.000677	0.00309	CbGeAlD
Dasatinib—EPHA4—nervous system—Alzheimer's disease	0.000676	0.00309	CbGeAlD
Dasatinib—ERBB3—nervous system—Alzheimer's disease	0.000669	0.00306	CbGeAlD
Dasatinib—TNK2—brain—Alzheimer's disease	0.000668	0.00305	CbGeAlD
Dasatinib—MAP3K2—nervous system—Alzheimer's disease	0.000663	0.00303	CbGeAlD
Dasatinib—RIPK2—cerebellum—Alzheimer's disease	0.000658	0.003	CbGeAlD
Dasatinib—SIK1—central nervous system—Alzheimer's disease	0.000657	0.003	CbGeAlD
Dasatinib—EPHA4—central nervous system—Alzheimer's disease	0.000651	0.00297	CbGeAlD
Dasatinib—ERBB3—central nervous system—Alzheimer's disease	0.000644	0.00294	CbGeAlD
Dasatinib—SIK1—cerebellum—Alzheimer's disease	0.000642	0.00293	CbGeAlD
Dasatinib—MAP3K2—central nervous system—Alzheimer's disease	0.000638	0.00291	CbGeAlD
Dasatinib—EPHA4—cerebellum—Alzheimer's disease	0.000636	0.0029	CbGeAlD
Dasatinib—ERBB3—cerebellum—Alzheimer's disease	0.00063	0.00288	CbGeAlD
Dasatinib—TESK1—brain—Alzheimer's disease	0.000628	0.00287	CbGeAlD
Dasatinib—MAP3K2—cerebellum—Alzheimer's disease	0.000624	0.00285	CbGeAlD
Dasatinib—MAPK14—nervous system—Alzheimer's disease	0.000623	0.00285	CbGeAlD
Dasatinib—FGR—nervous system—Alzheimer's disease	0.00062	0.00283	CbGeAlD
Dasatinib—STK36—brain—Alzheimer's disease	0.000618	0.00282	CbGeAlD
Dasatinib—EPHB3—brain—Alzheimer's disease	0.000618	0.00282	CbGeAlD
Dasatinib—ABL1—telencephalon—Alzheimer's disease	0.000604	0.00276	CbGeAlD
Dasatinib—MAPK14—central nervous system—Alzheimer's disease	0.0006	0.00274	CbGeAlD
Dasatinib—FMO3—nervous system—Alzheimer's disease	0.000599	0.00274	CbGeAlD
Dasatinib—LIMK2—brain—Alzheimer's disease	0.000598	0.00273	CbGeAlD
Dasatinib—FGR—central nervous system—Alzheimer's disease	0.000597	0.00273	CbGeAlD
Dasatinib—JAK2—nervous system—Alzheimer's disease	0.000586	0.00268	CbGeAlD
Dasatinib—MAPK14—cerebellum—Alzheimer's disease	0.000586	0.00268	CbGeAlD
Dasatinib—STK35—brain—Alzheimer's disease	0.000579	0.00265	CbGeAlD
Dasatinib—EPHA2—nervous system—Alzheimer's disease	0.000579	0.00265	CbGeAlD
Dasatinib—FYN—nervous system—Alzheimer's disease	0.000578	0.00264	CbGeAlD
Dasatinib—FMO3—central nervous system—Alzheimer's disease	0.000577	0.00264	CbGeAlD
Dasatinib—CSK—brain—Alzheimer's disease	0.000576	0.00263	CbGeAlD
Dasatinib—HCK—brain—Alzheimer's disease	0.000568	0.0026	CbGeAlD
Dasatinib—MAP4K5—nervous system—Alzheimer's disease	0.000565	0.00258	CbGeAlD
Dasatinib—MAP3K3—nervous system—Alzheimer's disease	0.000565	0.00258	CbGeAlD
Dasatinib—ABL2—brain—Alzheimer's disease	0.000565	0.00258	CbGeAlD
Dasatinib—JAK2—central nervous system—Alzheimer's disease	0.000565	0.00258	CbGeAlD
Dasatinib—EPHA2—central nervous system—Alzheimer's disease	0.000558	0.00255	CbGeAlD
Dasatinib—FYN—central nervous system—Alzheimer's disease	0.000557	0.00254	CbGeAlD
Dasatinib—EPHB4—cerebellum—Alzheimer's disease	0.000556	0.00254	CbGeAlD
Dasatinib—JAK2—cerebellum—Alzheimer's disease	0.000552	0.00252	CbGeAlD
Dasatinib—FYN—cerebellum—Alzheimer's disease	0.000544	0.00249	CbGeAlD
Dasatinib—MAP3K3—central nervous system—Alzheimer's disease	0.000544	0.00249	CbGeAlD
Dasatinib—MAP4K5—central nervous system—Alzheimer's disease	0.000544	0.00249	CbGeAlD
Dasatinib—EPHB6—nervous system—Alzheimer's disease	0.00054	0.00247	CbGeAlD
Dasatinib—RIPK2—brain—Alzheimer's disease	0.000534	0.00244	CbGeAlD
Dasatinib—MAP3K3—cerebellum—Alzheimer's disease	0.000532	0.00243	CbGeAlD
Dasatinib—MAP4K5—cerebellum—Alzheimer's disease	0.000532	0.00243	CbGeAlD
Dasatinib—YES1—nervous system—Alzheimer's disease	0.000522	0.00238	CbGeAlD
Dasatinib—SIK1—brain—Alzheimer's disease	0.000522	0.00238	CbGeAlD
Dasatinib—EPHB6—central nervous system—Alzheimer's disease	0.00052	0.00238	CbGeAlD
Dasatinib—EPHA4—brain—Alzheimer's disease	0.000516	0.00236	CbGeAlD
Dasatinib—PDGFRA—nervous system—Alzheimer's disease	0.000512	0.00234	CbGeAlD
Dasatinib—Myalgia—Galantamine—Alzheimer's disease	0.000512	0.00146	CcSEcCtD
Dasatinib—Arthralgia—Galantamine—Alzheimer's disease	0.000512	0.00146	CcSEcCtD
Dasatinib—ERBB3—brain—Alzheimer's disease	0.000511	0.00234	CbGeAlD
Dasatinib—CYP1B1—telencephalon—Alzheimer's disease	0.000511	0.00233	CbGeAlD
Dasatinib—Epistaxis—Memantine—Alzheimer's disease	0.000511	0.00145	CcSEcCtD
Dasatinib—Anxiety—Galantamine—Alzheimer's disease	0.00051	0.00145	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000508	0.00145	CcSEcCtD
Dasatinib—EPHB6—cerebellum—Alzheimer's disease	0.000508	0.00232	CbGeAlD
Dasatinib—MAP3K2—brain—Alzheimer's disease	0.000506	0.00231	CbGeAlD
Dasatinib—Discomfort—Galantamine—Alzheimer's disease	0.000506	0.00144	CcSEcCtD
Dasatinib—Haematuria—Rivastigmine—Alzheimer's disease	0.000505	0.00144	CcSEcCtD
Dasatinib—YES1—central nervous system—Alzheimer's disease	0.000503	0.0023	CbGeAlD
Dasatinib—SRC—nervous system—Alzheimer's disease	0.000502	0.00229	CbGeAlD
Dasatinib—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000501	0.00143	CcSEcCtD
Dasatinib—Epistaxis—Rivastigmine—Alzheimer's disease	0.0005	0.00142	CcSEcCtD
Dasatinib—Tinnitus—Donepezil—Alzheimer's disease	0.000499	0.00142	CcSEcCtD
Dasatinib—Confusional state—Galantamine—Alzheimer's disease	0.000495	0.00141	CcSEcCtD
Dasatinib—PDGFRA—central nervous system—Alzheimer's disease	0.000493	0.00225	CbGeAlD
Dasatinib—YES1—cerebellum—Alzheimer's disease	0.000491	0.00224	CbGeAlD
Dasatinib—Haemoglobin—Memantine—Alzheimer's disease	0.000488	0.00139	CcSEcCtD
Dasatinib—Hepatitis—Memantine—Alzheimer's disease	0.000486	0.00138	CcSEcCtD
Dasatinib—Haemorrhage—Memantine—Alzheimer's disease	0.000486	0.00138	CcSEcCtD
Dasatinib—SRC—central nervous system—Alzheimer's disease	0.000483	0.00221	CbGeAlD
Dasatinib—Shock—Galantamine—Alzheimer's disease	0.000483	0.00137	CcSEcCtD
Dasatinib—PDGFRA—cerebellum—Alzheimer's disease	0.000482	0.0022	CbGeAlD
Dasatinib—Nervous system disorder—Galantamine—Alzheimer's disease	0.000481	0.00137	CcSEcCtD
Dasatinib—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00048	0.00137	CcSEcCtD
Dasatinib—Chills—Donepezil—Alzheimer's disease	0.00048	0.00137	CcSEcCtD
Dasatinib—Urinary tract disorder—Memantine—Alzheimer's disease	0.00048	0.00137	CcSEcCtD
Dasatinib—Tachycardia—Galantamine—Alzheimer's disease	0.000479	0.00136	CcSEcCtD
Dasatinib—Oedema peripheral—Memantine—Alzheimer's disease	0.000479	0.00136	CcSEcCtD
Dasatinib—Arrhythmia—Donepezil—Alzheimer's disease	0.000478	0.00136	CcSEcCtD
Dasatinib—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000478	0.00136	CcSEcCtD
Dasatinib—Connective tissue disorder—Memantine—Alzheimer's disease	0.000478	0.00136	CcSEcCtD
Dasatinib—Skin disorder—Galantamine—Alzheimer's disease	0.000477	0.00136	CcSEcCtD
Dasatinib—Urethral disorder—Memantine—Alzheimer's disease	0.000476	0.00136	CcSEcCtD
Dasatinib—MAPK14—brain—Alzheimer's disease	0.000476	0.00217	CbGeAlD
Dasatinib—Hepatitis—Rivastigmine—Alzheimer's disease	0.000475	0.00135	CcSEcCtD
Dasatinib—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000475	0.00135	CcSEcCtD
Dasatinib—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000474	0.00135	CcSEcCtD
Dasatinib—FGR—brain—Alzheimer's disease	0.000474	0.00217	CbGeAlD
Dasatinib—Alopecia—Donepezil—Alzheimer's disease	0.000473	0.00135	CcSEcCtD
Dasatinib—SRC—cerebellum—Alzheimer's disease	0.000473	0.00216	CbGeAlD
Dasatinib—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00047	0.00134	CcSEcCtD
Dasatinib—Mental disorder—Donepezil—Alzheimer's disease	0.000469	0.00133	CcSEcCtD
Dasatinib—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000468	0.00133	CcSEcCtD
Dasatinib—Visual impairment—Memantine—Alzheimer's disease	0.000468	0.00133	CcSEcCtD
Dasatinib—Anorexia—Galantamine—Alzheimer's disease	0.000468	0.00133	CcSEcCtD
Dasatinib—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000467	0.00133	CcSEcCtD
Dasatinib—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000466	0.00133	CcSEcCtD
Dasatinib—Malnutrition—Donepezil—Alzheimer's disease	0.000466	0.00133	CcSEcCtD
Dasatinib—Erythema—Donepezil—Alzheimer's disease	0.000466	0.00133	CcSEcCtD
Dasatinib—MAP2K5—nervous system—Alzheimer's disease	0.000462	0.00211	CbGeAlD
Dasatinib—Erythema multiforme—Memantine—Alzheimer's disease	0.00046	0.00131	CcSEcCtD
Dasatinib—Hypotension—Galantamine—Alzheimer's disease	0.000459	0.0013	CcSEcCtD
Dasatinib—Visual impairment—Rivastigmine—Alzheimer's disease	0.000458	0.0013	CcSEcCtD
Dasatinib—FMO3—brain—Alzheimer's disease	0.000458	0.00209	CbGeAlD
Dasatinib—Dysgeusia—Donepezil—Alzheimer's disease	0.000456	0.0013	CcSEcCtD
Dasatinib—Eye disorder—Memantine—Alzheimer's disease	0.000454	0.00129	CcSEcCtD
Dasatinib—Tinnitus—Memantine—Alzheimer's disease	0.000453	0.00129	CcSEcCtD
Dasatinib—EPHB4—brain—Alzheimer's disease	0.000451	0.00206	CbGeAlD
Dasatinib—Flushing—Memantine—Alzheimer's disease	0.000451	0.00128	CcSEcCtD
Dasatinib—Cardiac disorder—Memantine—Alzheimer's disease	0.000451	0.00128	CcSEcCtD
Dasatinib—CSF1R—nervous system—Alzheimer's disease	0.000451	0.00206	CbGeAlD
Dasatinib—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.00045	0.00128	CcSEcCtD
Dasatinib—JAK2—brain—Alzheimer's disease	0.000448	0.00205	CbGeAlD
Dasatinib—Muscle spasms—Donepezil—Alzheimer's disease	0.000448	0.00127	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000447	0.00127	CcSEcCtD
Dasatinib—MAP2K5—central nervous system—Alzheimer's disease	0.000445	0.00203	CbGeAlD
Dasatinib—Eye disorder—Rivastigmine—Alzheimer's disease	0.000444	0.00126	CcSEcCtD
Dasatinib—Insomnia—Galantamine—Alzheimer's disease	0.000444	0.00126	CcSEcCtD
Dasatinib—Tinnitus—Rivastigmine—Alzheimer's disease	0.000443	0.00126	CcSEcCtD
Dasatinib—EPHA2—brain—Alzheimer's disease	0.000443	0.00202	CbGeAlD
Dasatinib—FYN—brain—Alzheimer's disease	0.000442	0.00202	CbGeAlD
Dasatinib—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000441	0.00126	CcSEcCtD
Dasatinib—Flushing—Rivastigmine—Alzheimer's disease	0.000441	0.00126	CcSEcCtD
Dasatinib—Angiopathy—Memantine—Alzheimer's disease	0.000441	0.00125	CcSEcCtD
Dasatinib—Vision blurred—Donepezil—Alzheimer's disease	0.000439	0.00125	CcSEcCtD
Dasatinib—Immune system disorder—Memantine—Alzheimer's disease	0.000439	0.00125	CcSEcCtD
Dasatinib—Mediastinal disorder—Memantine—Alzheimer's disease	0.000438	0.00125	CcSEcCtD
Dasatinib—Tremor—Donepezil—Alzheimer's disease	0.000437	0.00124	CcSEcCtD
Dasatinib—Somnolence—Galantamine—Alzheimer's disease	0.000436	0.00124	CcSEcCtD
Dasatinib—Chills—Memantine—Alzheimer's disease	0.000436	0.00124	CcSEcCtD
Dasatinib—MAP2K5—cerebellum—Alzheimer's disease	0.000435	0.00199	CbGeAlD
Dasatinib—Arrhythmia—Memantine—Alzheimer's disease	0.000434	0.00124	CcSEcCtD
Dasatinib—CSF1R—central nervous system—Alzheimer's disease	0.000434	0.00198	CbGeAlD
Dasatinib—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000432	0.00123	CcSEcCtD
Dasatinib—MAP3K3—brain—Alzheimer's disease	0.000432	0.00197	CbGeAlD
Dasatinib—MAP4K5—brain—Alzheimer's disease	0.000432	0.00197	CbGeAlD
Dasatinib—Dyspepsia—Galantamine—Alzheimer's disease	0.000432	0.00123	CcSEcCtD
Dasatinib—Angiopathy—Rivastigmine—Alzheimer's disease	0.000431	0.00123	CcSEcCtD
Dasatinib—Anaemia—Donepezil—Alzheimer's disease	0.000431	0.00123	CcSEcCtD
Dasatinib—Alopecia—Memantine—Alzheimer's disease	0.000429	0.00122	CcSEcCtD
Dasatinib—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000429	0.00122	CcSEcCtD
Dasatinib—Chills—Rivastigmine—Alzheimer's disease	0.000427	0.00121	CcSEcCtD
Dasatinib—Decreased appetite—Galantamine—Alzheimer's disease	0.000427	0.00121	CcSEcCtD
Dasatinib—Mental disorder—Memantine—Alzheimer's disease	0.000426	0.00121	CcSEcCtD
Dasatinib—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000425	0.00121	CcSEcCtD
Dasatinib—CSF1R—cerebellum—Alzheimer's disease	0.000424	0.00194	CbGeAlD
Dasatinib—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000424	0.00121	CcSEcCtD
Dasatinib—Malnutrition—Memantine—Alzheimer's disease	0.000423	0.0012	CcSEcCtD
Dasatinib—Fatigue—Galantamine—Alzheimer's disease	0.000423	0.0012	CcSEcCtD
Dasatinib—Malaise—Donepezil—Alzheimer's disease	0.00042	0.0012	CcSEcCtD
Dasatinib—Alopecia—Rivastigmine—Alzheimer's disease	0.00042	0.0012	CcSEcCtD
Dasatinib—Constipation—Galantamine—Alzheimer's disease	0.00042	0.00119	CcSEcCtD
Dasatinib—Vertigo—Donepezil—Alzheimer's disease	0.000419	0.00119	CcSEcCtD
Dasatinib—Syncope—Donepezil—Alzheimer's disease	0.000418	0.00119	CcSEcCtD
Dasatinib—Mental disorder—Rivastigmine—Alzheimer's disease	0.000417	0.00119	CcSEcCtD
Dasatinib—Dysgeusia—Memantine—Alzheimer's disease	0.000414	0.00118	CcSEcCtD
Dasatinib—Malnutrition—Rivastigmine—Alzheimer's disease	0.000414	0.00118	CcSEcCtD
Dasatinib—Erythema—Rivastigmine—Alzheimer's disease	0.000414	0.00118	CcSEcCtD
Dasatinib—EPHB6—brain—Alzheimer's disease	0.000413	0.00189	CbGeAlD
Dasatinib—Loss of consciousness—Donepezil—Alzheimer's disease	0.00041	0.00117	CcSEcCtD
Dasatinib—KIT—nervous system—Alzheimer's disease	0.000409	0.00187	CbGeAlD
Dasatinib—Cough—Donepezil—Alzheimer's disease	0.000407	0.00116	CcSEcCtD
Dasatinib—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000405	0.00115	CcSEcCtD
Dasatinib—Feeling abnormal—Galantamine—Alzheimer's disease	0.000404	0.00115	CcSEcCtD
Dasatinib—Convulsion—Donepezil—Alzheimer's disease	0.000404	0.00115	CcSEcCtD
Dasatinib—Hypertension—Donepezil—Alzheimer's disease	0.000402	0.00114	CcSEcCtD
Dasatinib—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000401	0.00114	CcSEcCtD
Dasatinib—PDGFRB—nervous system—Alzheimer's disease	0.0004	0.00183	CbGeAlD
Dasatinib—YES1—brain—Alzheimer's disease	0.000399	0.00182	CbGeAlD
Dasatinib—Vision blurred—Memantine—Alzheimer's disease	0.000399	0.00113	CcSEcCtD
Dasatinib—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000398	0.00113	CcSEcCtD
Dasatinib—Myalgia—Donepezil—Alzheimer's disease	0.000397	0.00113	CcSEcCtD
Dasatinib—Chest pain—Donepezil—Alzheimer's disease	0.000397	0.00113	CcSEcCtD
Dasatinib—Arthralgia—Donepezil—Alzheimer's disease	0.000397	0.00113	CcSEcCtD
Dasatinib—Tremor—Memantine—Alzheimer's disease	0.000396	0.00113	CcSEcCtD
Dasatinib—Anxiety—Donepezil—Alzheimer's disease	0.000395	0.00112	CcSEcCtD
Dasatinib—KIT—central nervous system—Alzheimer's disease	0.000394	0.0018	CbGeAlD
Dasatinib—Ill-defined disorder—Memantine—Alzheimer's disease	0.000393	0.00112	CcSEcCtD
Dasatinib—Discomfort—Donepezil—Alzheimer's disease	0.000392	0.00112	CcSEcCtD
Dasatinib—PDGFRA—brain—Alzheimer's disease	0.000391	0.00179	CbGeAlD
Dasatinib—Anaemia—Memantine—Alzheimer's disease	0.000391	0.00111	CcSEcCtD
Dasatinib—Vision blurred—Rivastigmine—Alzheimer's disease	0.00039	0.00111	CcSEcCtD
Dasatinib—Body temperature increased—Galantamine—Alzheimer's disease	0.000388	0.0011	CcSEcCtD
Dasatinib—Abdominal pain—Galantamine—Alzheimer's disease	0.000388	0.0011	CcSEcCtD
Dasatinib—Tremor—Rivastigmine—Alzheimer's disease	0.000388	0.0011	CcSEcCtD
Dasatinib—ABCB1—blood vessel—Alzheimer's disease	0.000387	0.00177	CbGeAlD
Dasatinib—KIT—cerebellum—Alzheimer's disease	0.000385	0.00176	CbGeAlD
Dasatinib—PDGFRB—central nervous system—Alzheimer's disease	0.000385	0.00176	CbGeAlD
Dasatinib—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000384	0.00109	CcSEcCtD
Dasatinib—SRC—brain—Alzheimer's disease	0.000384	0.00175	CbGeAlD
Dasatinib—Confusional state—Donepezil—Alzheimer's disease	0.000383	0.00109	CcSEcCtD
Dasatinib—Anaemia—Rivastigmine—Alzheimer's disease	0.000383	0.00109	CcSEcCtD
Dasatinib—Malaise—Memantine—Alzheimer's disease	0.000382	0.00109	CcSEcCtD
Dasatinib—ABCG2—telencephalon—Alzheimer's disease	0.000381	0.00174	CbGeAlD
Dasatinib—Oedema—Donepezil—Alzheimer's disease	0.00038	0.00108	CcSEcCtD
Dasatinib—Vertigo—Memantine—Alzheimer's disease	0.00038	0.00108	CcSEcCtD
Dasatinib—Syncope—Memantine—Alzheimer's disease	0.000379	0.00108	CcSEcCtD
Dasatinib—Infection—Donepezil—Alzheimer's disease	0.000378	0.00108	CcSEcCtD
Dasatinib—PDGFRB—cerebellum—Alzheimer's disease	0.000376	0.00172	CbGeAlD
Dasatinib—Shock—Donepezil—Alzheimer's disease	0.000374	0.00106	CcSEcCtD
Dasatinib—Palpitations—Memantine—Alzheimer's disease	0.000374	0.00106	CcSEcCtD
Dasatinib—Malaise—Rivastigmine—Alzheimer's disease	0.000373	0.00106	CcSEcCtD
Dasatinib—Nervous system disorder—Donepezil—Alzheimer's disease	0.000373	0.00106	CcSEcCtD
Dasatinib—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000372	0.00106	CcSEcCtD
Dasatinib—Vertigo—Rivastigmine—Alzheimer's disease	0.000372	0.00106	CcSEcCtD
Dasatinib—Loss of consciousness—Memantine—Alzheimer's disease	0.000372	0.00106	CcSEcCtD
Dasatinib—Syncope—Rivastigmine—Alzheimer's disease	0.000371	0.00106	CcSEcCtD
Dasatinib—Cough—Memantine—Alzheimer's disease	0.000369	0.00105	CcSEcCtD
Dasatinib—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000368	0.00105	CcSEcCtD
Dasatinib—Convulsion—Memantine—Alzheimer's disease	0.000367	0.00104	CcSEcCtD
Dasatinib—Palpitations—Rivastigmine—Alzheimer's disease	0.000366	0.00104	CcSEcCtD
Dasatinib—Hypertension—Memantine—Alzheimer's disease	0.000365	0.00104	CcSEcCtD
Dasatinib—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000364	0.00104	CcSEcCtD
Dasatinib—Anorexia—Donepezil—Alzheimer's disease	0.000363	0.00103	CcSEcCtD
Dasatinib—Hypersensitivity—Galantamine—Alzheimer's disease	0.000362	0.00103	CcSEcCtD
Dasatinib—Cough—Rivastigmine—Alzheimer's disease	0.000361	0.00103	CcSEcCtD
Dasatinib—Chest pain—Memantine—Alzheimer's disease	0.00036	0.00102	CcSEcCtD
Dasatinib—Arthralgia—Memantine—Alzheimer's disease	0.00036	0.00102	CcSEcCtD
Dasatinib—Myalgia—Memantine—Alzheimer's disease	0.00036	0.00102	CcSEcCtD
Dasatinib—Anxiety—Memantine—Alzheimer's disease	0.000359	0.00102	CcSEcCtD
Dasatinib—Convulsion—Rivastigmine—Alzheimer's disease	0.000359	0.00102	CcSEcCtD
Dasatinib—Hypertension—Rivastigmine—Alzheimer's disease	0.000357	0.00102	CcSEcCtD
Dasatinib—ABL1—nervous system—Alzheimer's disease	0.000356	0.00163	CbGeAlD
Dasatinib—Discomfort—Memantine—Alzheimer's disease	0.000356	0.00101	CcSEcCtD
Dasatinib—Hypotension—Donepezil—Alzheimer's disease	0.000355	0.00101	CcSEcCtD
Dasatinib—MAP2K5—brain—Alzheimer's disease	0.000353	0.00161	CbGeAlD
Dasatinib—Chest pain—Rivastigmine—Alzheimer's disease	0.000352	0.001	CcSEcCtD
Dasatinib—Myalgia—Rivastigmine—Alzheimer's disease	0.000352	0.001	CcSEcCtD
Dasatinib—Arthralgia—Rivastigmine—Alzheimer's disease	0.000352	0.001	CcSEcCtD
Dasatinib—Asthenia—Galantamine—Alzheimer's disease	0.000352	0.001	CcSEcCtD
Dasatinib—Anxiety—Rivastigmine—Alzheimer's disease	0.000351	0.000999	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00035	0.000996	CcSEcCtD
Dasatinib—Confusional state—Memantine—Alzheimer's disease	0.000348	0.000991	CcSEcCtD
Dasatinib—Discomfort—Rivastigmine—Alzheimer's disease	0.000348	0.000991	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000346	0.000986	CcSEcCtD
Dasatinib—Oedema—Memantine—Alzheimer's disease	0.000345	0.000983	CcSEcCtD
Dasatinib—CSF1R—brain—Alzheimer's disease	0.000345	0.00157	CbGeAlD
Dasatinib—Insomnia—Donepezil—Alzheimer's disease	0.000344	0.000979	CcSEcCtD
Dasatinib—ABL1—central nervous system—Alzheimer's disease	0.000343	0.00157	CbGeAlD
Dasatinib—Infection—Memantine—Alzheimer's disease	0.000343	0.000976	CcSEcCtD
Dasatinib—Confusional state—Rivastigmine—Alzheimer's disease	0.000341	0.000969	CcSEcCtD
Dasatinib—Shock—Memantine—Alzheimer's disease	0.00034	0.000967	CcSEcCtD
Dasatinib—Dyspnoea—Donepezil—Alzheimer's disease	0.000339	0.000965	CcSEcCtD
Dasatinib—Nervous system disorder—Memantine—Alzheimer's disease	0.000339	0.000964	CcSEcCtD
Dasatinib—Somnolence—Donepezil—Alzheimer's disease	0.000338	0.000962	CcSEcCtD
Dasatinib—Thrombocytopenia—Memantine—Alzheimer's disease	0.000338	0.000962	CcSEcCtD
Dasatinib—Oedema—Rivastigmine—Alzheimer's disease	0.000338	0.000961	CcSEcCtD
Dasatinib—Tachycardia—Memantine—Alzheimer's disease	0.000337	0.000959	CcSEcCtD
Dasatinib—Diarrhoea—Galantamine—Alzheimer's disease	0.000336	0.000955	CcSEcCtD
Dasatinib—Infection—Rivastigmine—Alzheimer's disease	0.000336	0.000955	CcSEcCtD
Dasatinib—Skin disorder—Memantine—Alzheimer's disease	0.000335	0.000954	CcSEcCtD
Dasatinib—ABL1—cerebellum—Alzheimer's disease	0.000335	0.00153	CbGeAlD
Dasatinib—Dyspepsia—Donepezil—Alzheimer's disease	0.000335	0.000953	CcSEcCtD
Dasatinib—Hyperhidrosis—Memantine—Alzheimer's disease	0.000334	0.00095	CcSEcCtD
Dasatinib—Shock—Rivastigmine—Alzheimer's disease	0.000332	0.000946	CcSEcCtD
Dasatinib—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000331	0.000943	CcSEcCtD
Dasatinib—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000331	0.000941	CcSEcCtD
Dasatinib—Decreased appetite—Donepezil—Alzheimer's disease	0.000331	0.000941	CcSEcCtD
Dasatinib—Tachycardia—Rivastigmine—Alzheimer's disease	0.00033	0.000938	CcSEcCtD
Dasatinib—Anorexia—Memantine—Alzheimer's disease	0.000329	0.000937	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000328	0.000934	CcSEcCtD
Dasatinib—Skin disorder—Rivastigmine—Alzheimer's disease	0.000328	0.000934	CcSEcCtD
Dasatinib—Fatigue—Donepezil—Alzheimer's disease	0.000328	0.000933	CcSEcCtD
Dasatinib—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000327	0.000929	CcSEcCtD
Dasatinib—Pain—Donepezil—Alzheimer's disease	0.000325	0.000925	CcSEcCtD
Dasatinib—Constipation—Donepezil—Alzheimer's disease	0.000325	0.000925	CcSEcCtD
Dasatinib—Dizziness—Galantamine—Alzheimer's disease	0.000325	0.000923	CcSEcCtD
Dasatinib—Hypotension—Memantine—Alzheimer's disease	0.000323	0.000918	CcSEcCtD
Dasatinib—Anorexia—Rivastigmine—Alzheimer's disease	0.000322	0.000916	CcSEcCtD
Dasatinib—Hypotension—Rivastigmine—Alzheimer's disease	0.000316	0.000898	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000315	0.000895	CcSEcCtD
Dasatinib—Feeling abnormal—Donepezil—Alzheimer's disease	0.000313	0.000892	CcSEcCtD
Dasatinib—KIT—brain—Alzheimer's disease	0.000313	0.00143	CbGeAlD
Dasatinib—Insomnia—Memantine—Alzheimer's disease	0.000312	0.000889	CcSEcCtD
Dasatinib—Vomiting—Galantamine—Alzheimer's disease	0.000312	0.000888	CcSEcCtD
Dasatinib—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000311	0.000885	CcSEcCtD
Dasatinib—Rash—Galantamine—Alzheimer's disease	0.000309	0.00088	CcSEcCtD
Dasatinib—Dermatitis—Galantamine—Alzheimer's disease	0.000309	0.00088	CcSEcCtD
Dasatinib—Dyspnoea—Memantine—Alzheimer's disease	0.000308	0.000876	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000308	0.000876	CcSEcCtD
Dasatinib—Headache—Galantamine—Alzheimer's disease	0.000307	0.000875	CcSEcCtD
Dasatinib—Somnolence—Memantine—Alzheimer's disease	0.000307	0.000874	CcSEcCtD
Dasatinib—PDGFRB—brain—Alzheimer's disease	0.000306	0.0014	CbGeAlD
Dasatinib—Insomnia—Rivastigmine—Alzheimer's disease	0.000306	0.000869	CcSEcCtD
Dasatinib—Dyspepsia—Memantine—Alzheimer's disease	0.000304	0.000865	CcSEcCtD
Dasatinib—Urticaria—Donepezil—Alzheimer's disease	0.000302	0.00086	CcSEcCtD
Dasatinib—CYP1B1—nervous system—Alzheimer's disease	0.000302	0.00138	CbGeAlD
Dasatinib—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000301	0.000857	CcSEcCtD
Dasatinib—Body temperature increased—Donepezil—Alzheimer's disease	0.000301	0.000855	CcSEcCtD
Dasatinib—Abdominal pain—Donepezil—Alzheimer's disease	0.000301	0.000855	CcSEcCtD
Dasatinib—Somnolence—Rivastigmine—Alzheimer's disease	0.0003	0.000855	CcSEcCtD
Dasatinib—Decreased appetite—Memantine—Alzheimer's disease	0.0003	0.000854	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000298	0.000848	CcSEcCtD
Dasatinib—Fatigue—Memantine—Alzheimer's disease	0.000298	0.000847	CcSEcCtD
Dasatinib—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000297	0.000846	CcSEcCtD
Dasatinib—Pain—Memantine—Alzheimer's disease	0.000295	0.00084	CcSEcCtD
Dasatinib—Constipation—Memantine—Alzheimer's disease	0.000295	0.00084	CcSEcCtD
Dasatinib—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000294	0.000836	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000292	0.00083	CcSEcCtD
Dasatinib—Nausea—Galantamine—Alzheimer's disease	0.000291	0.000829	CcSEcCtD
Dasatinib—Fatigue—Rivastigmine—Alzheimer's disease	0.000291	0.000829	CcSEcCtD
Dasatinib—CYP1B1—central nervous system—Alzheimer's disease	0.000291	0.00133	CbGeAlD
Dasatinib—Constipation—Rivastigmine—Alzheimer's disease	0.000289	0.000822	CcSEcCtD
Dasatinib—Pain—Rivastigmine—Alzheimer's disease	0.000289	0.000822	CcSEcCtD
Dasatinib—Feeling abnormal—Memantine—Alzheimer's disease	0.000285	0.00081	CcSEcCtD
Dasatinib—CYP1B1—cerebellum—Alzheimer's disease	0.000284	0.0013	CbGeAlD
Dasatinib—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000282	0.000803	CcSEcCtD
Dasatinib—Hypersensitivity—Donepezil—Alzheimer's disease	0.00028	0.000797	CcSEcCtD
Dasatinib—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000278	0.000792	CcSEcCtD
Dasatinib—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000276	0.000786	CcSEcCtD
Dasatinib—Urticaria—Memantine—Alzheimer's disease	0.000274	0.000781	CcSEcCtD
Dasatinib—Body temperature increased—Memantine—Alzheimer's disease	0.000273	0.000777	CcSEcCtD
Dasatinib—Abdominal pain—Memantine—Alzheimer's disease	0.000273	0.000777	CcSEcCtD
Dasatinib—Asthenia—Donepezil—Alzheimer's disease	0.000273	0.000776	CcSEcCtD
Dasatinib—ABL1—brain—Alzheimer's disease	0.000272	0.00124	CbGeAlD
Dasatinib—Pruritus—Donepezil—Alzheimer's disease	0.000269	0.000766	CcSEcCtD
Dasatinib—Urticaria—Rivastigmine—Alzheimer's disease	0.000268	0.000764	CcSEcCtD
Dasatinib—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000267	0.00076	CcSEcCtD
Dasatinib—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000267	0.00076	CcSEcCtD
Dasatinib—Diarrhoea—Donepezil—Alzheimer's disease	0.00026	0.00074	CcSEcCtD
Dasatinib—Hypersensitivity—Memantine—Alzheimer's disease	0.000254	0.000724	CcSEcCtD
Dasatinib—Dizziness—Donepezil—Alzheimer's disease	0.000251	0.000716	CcSEcCtD
Dasatinib—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000249	0.000708	CcSEcCtD
Dasatinib—Asthenia—Memantine—Alzheimer's disease	0.000248	0.000705	CcSEcCtD
Dasatinib—Pruritus—Memantine—Alzheimer's disease	0.000244	0.000695	CcSEcCtD
Dasatinib—Asthenia—Rivastigmine—Alzheimer's disease	0.000242	0.00069	CcSEcCtD
Dasatinib—Vomiting—Donepezil—Alzheimer's disease	0.000242	0.000688	CcSEcCtD
Dasatinib—Rash—Donepezil—Alzheimer's disease	0.00024	0.000682	CcSEcCtD
Dasatinib—Dermatitis—Donepezil—Alzheimer's disease	0.00024	0.000682	CcSEcCtD
Dasatinib—Pruritus—Rivastigmine—Alzheimer's disease	0.000239	0.00068	CcSEcCtD
Dasatinib—Headache—Donepezil—Alzheimer's disease	0.000238	0.000678	CcSEcCtD
Dasatinib—Diarrhoea—Memantine—Alzheimer's disease	0.000236	0.000672	CcSEcCtD
Dasatinib—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000231	0.000658	CcSEcCtD
Dasatinib—ABCB1—embryo—Alzheimer's disease	0.000231	0.00105	CbGeAlD
Dasatinib—CYP1B1—brain—Alzheimer's disease	0.000231	0.00105	CbGeAlD
Dasatinib—Dizziness—Memantine—Alzheimer's disease	0.000228	0.00065	CcSEcCtD
Dasatinib—Nausea—Donepezil—Alzheimer's disease	0.000226	0.000643	CcSEcCtD
Dasatinib—Dizziness—Rivastigmine—Alzheimer's disease	0.000223	0.000636	CcSEcCtD
Dasatinib—Vomiting—Memantine—Alzheimer's disease	0.00022	0.000625	CcSEcCtD
Dasatinib—Rash—Memantine—Alzheimer's disease	0.000218	0.00062	CcSEcCtD
Dasatinib—Dermatitis—Memantine—Alzheimer's disease	0.000218	0.000619	CcSEcCtD
Dasatinib—Headache—Memantine—Alzheimer's disease	0.000216	0.000616	CcSEcCtD
Dasatinib—Vomiting—Rivastigmine—Alzheimer's disease	0.000215	0.000611	CcSEcCtD
Dasatinib—CYP1A1—nervous system—Alzheimer's disease	0.000213	0.000974	CbGeAlD
Dasatinib—Rash—Rivastigmine—Alzheimer's disease	0.000213	0.000606	CcSEcCtD
Dasatinib—Dermatitis—Rivastigmine—Alzheimer's disease	0.000213	0.000606	CcSEcCtD
Dasatinib—Headache—Rivastigmine—Alzheimer's disease	0.000212	0.000602	CcSEcCtD
Dasatinib—ABCG2—cerebellum—Alzheimer's disease	0.000211	0.000966	CbGeAlD
Dasatinib—CYP1A1—central nervous system—Alzheimer's disease	0.000205	0.000938	CbGeAlD
Dasatinib—Nausea—Memantine—Alzheimer's disease	0.000205	0.000584	CcSEcCtD
Dasatinib—ABCB1—forebrain—Alzheimer's disease	0.000204	0.000932	CbGeAlD
Dasatinib—Nausea—Rivastigmine—Alzheimer's disease	0.000201	0.000571	CcSEcCtD
Dasatinib—ABCB1—telencephalon—Alzheimer's disease	0.000188	0.000857	CbGeAlD
Dasatinib—ABCG2—brain—Alzheimer's disease	0.000172	0.000785	CbGeAlD
Dasatinib—CYP1A1—brain—Alzheimer's disease	0.000163	0.000745	CbGeAlD
Dasatinib—CYP3A4—nervous system—Alzheimer's disease	0.000157	0.000715	CbGeAlD
Dasatinib—CYP3A4—central nervous system—Alzheimer's disease	0.000151	0.000688	CbGeAlD
Dasatinib—ABCB1—nervous system—Alzheimer's disease	0.000111	0.000506	CbGeAlD
Dasatinib—ABCB1—central nervous system—Alzheimer's disease	0.000107	0.000487	CbGeAlD
Dasatinib—ABCB1—cerebellum—Alzheimer's disease	0.000104	0.000476	CbGeAlD
Dasatinib—ABCB1—brain—Alzheimer's disease	8.47e-05	0.000387	CbGeAlD
Dasatinib—MAPK14—Signaling Pathways—IGF1—Alzheimer's disease	2.1e-06	4.88e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—ESR1—Alzheimer's disease	2.09e-06	4.87e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ACHE—Alzheimer's disease	2.09e-06	4.87e-06	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—NOS3—Alzheimer's disease	2.09e-06	4.87e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—ABCA1—Alzheimer's disease	2.09e-06	4.86e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—HTR2A—Alzheimer's disease	2.09e-06	4.86e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CHAT—Alzheimer's disease	2.08e-06	4.85e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—TPI1—Alzheimer's disease	2.08e-06	4.85e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—NOS3—Alzheimer's disease	2.08e-06	4.83e-06	CbGpPWpGaD
Dasatinib—YES1—Immune System—IL6—Alzheimer's disease	2.07e-06	4.82e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IGF1—Alzheimer's disease	2.07e-06	4.82e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	2.07e-06	4.81e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—F2—Alzheimer's disease	2.07e-06	4.81e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—LPL—Alzheimer's disease	2.05e-06	4.78e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—NOS3—Alzheimer's disease	2.05e-06	4.77e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—CASP3—Alzheimer's disease	2.04e-06	4.74e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—TGFB1—Alzheimer's disease	2.03e-06	4.71e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—NOTCH1—Alzheimer's disease	2.02e-06	4.71e-06	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—AKT1—Alzheimer's disease	2.01e-06	4.68e-06	CbGpPWpGaD
Dasatinib—ERBB3—Disease—AKT1—Alzheimer's disease	2.01e-06	4.68e-06	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—AKT1—Alzheimer's disease	2.01e-06	4.67e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—NOS3—Alzheimer's disease	2e-06	4.67e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—MAOB—Alzheimer's disease	2e-06	4.65e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—MAPK8—Alzheimer's disease	1.98e-06	4.62e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—NOS3—Alzheimer's disease	1.97e-06	4.59e-06	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—AKT1—Alzheimer's disease	1.97e-06	4.59e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	1.96e-06	4.56e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ENO1—Alzheimer's disease	1.96e-06	4.56e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	1.96e-06	4.55e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CALM1—Alzheimer's disease	1.95e-06	4.54e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—APOE—Alzheimer's disease	1.94e-06	4.52e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—LEP—Alzheimer's disease	1.94e-06	4.52e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—VEGFA—Alzheimer's disease	1.94e-06	4.51e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—TGFB1—Alzheimer's disease	1.93e-06	4.5e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—CASP3—Alzheimer's disease	1.93e-06	4.49e-06	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—AKT1—Alzheimer's disease	1.93e-06	4.48e-06	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—IL6—Alzheimer's disease	1.92e-06	4.48e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CAV1—Alzheimer's disease	1.92e-06	4.48e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	1.92e-06	4.48e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.92e-06	4.47e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL1B—Alzheimer's disease	1.91e-06	4.46e-06	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—PTGS2—Alzheimer's disease	1.91e-06	4.45e-06	CbGpPWpGaD
Dasatinib—YES1—Immune System—AKT1—Alzheimer's disease	1.91e-06	4.45e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—NOS3—Alzheimer's disease	1.9e-06	4.43e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—NOS3—Alzheimer's disease	1.9e-06	4.42e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—PTGS2—Alzheimer's disease	1.9e-06	4.42e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—GSK3B—Alzheimer's disease	1.9e-06	4.42e-06	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—TP53—Alzheimer's disease	1.89e-06	4.4e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CREB1—Alzheimer's disease	1.88e-06	4.39e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—NOS3—Alzheimer's disease	1.88e-06	4.37e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—INS—Alzheimer's disease	1.87e-06	4.36e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—MAPK8—Alzheimer's disease	1.87e-06	4.36e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—TGFB1—Alzheimer's disease	1.86e-06	4.34e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.86e-06	4.32e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—ESR1—Alzheimer's disease	1.85e-06	4.31e-06	CbGpPWpGaD
Dasatinib—KIT—Immune System—IL6—Alzheimer's disease	1.85e-06	4.31e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—MTHFR—Alzheimer's disease	1.85e-06	4.3e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CCL2—Alzheimer's disease	1.84e-06	4.29e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—F2—Alzheimer's disease	1.83e-06	4.26e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—CALM1—Alzheimer's disease	1.83e-06	4.25e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—BCHE—Alzheimer's disease	1.82e-06	4.24e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—APOE—Alzheimer's disease	1.82e-06	4.24e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IGF1—Alzheimer's disease	1.81e-06	4.22e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—CAV1—Alzheimer's disease	1.8e-06	4.2e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	1.8e-06	4.19e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—HMOX1—Alzheimer's disease	1.79e-06	4.17e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NOTCH1—Alzheimer's disease	1.79e-06	4.17e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—TGFB1—Alzheimer's disease	1.78e-06	4.14e-06	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—AKT1—Alzheimer's disease	1.78e-06	4.13e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—MAPK8—Alzheimer's disease	1.77e-06	4.13e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—TGFB1—Alzheimer's disease	1.77e-06	4.12e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—MAPK8—Alzheimer's disease	1.76e-06	4.09e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—IL6—Alzheimer's disease	1.75e-06	4.08e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—PTGS2—Alzheimer's disease	1.74e-06	4.05e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CASP3—Alzheimer's disease	1.74e-06	4.05e-06	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—IL6—Alzheimer's disease	1.73e-06	4.03e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—VEGFA—Alzheimer's disease	1.73e-06	4.03e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—TP53—Alzheimer's disease	1.73e-06	4.03e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—CALM1—Alzheimer's disease	1.73e-06	4.02e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	1.72e-06	4e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—APOE—Alzheimer's disease	1.72e-06	4e-06	CbGpPWpGaD
Dasatinib—KIT—Disease—IL6—Alzheimer's disease	1.71e-06	3.98e-06	CbGpPWpGaD
Dasatinib—KIT—Immune System—AKT1—Alzheimer's disease	1.71e-06	3.97e-06	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—AKT1—Alzheimer's disease	1.71e-06	3.97e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—CAV1—Alzheimer's disease	1.7e-06	3.97e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CASP3—Alzheimer's disease	1.7e-06	3.96e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.69e-06	3.93e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—GSK3B—Alzheimer's disease	1.68e-06	3.91e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CASP3—Alzheimer's disease	1.68e-06	3.9e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CREB1—Alzheimer's disease	1.67e-06	3.88e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	1.67e-06	3.88e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—TP53—Alzheimer's disease	1.67e-06	3.88e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—INS—Alzheimer's disease	1.66e-06	3.86e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—NOS3—Alzheimer's disease	1.64e-06	3.82e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—LPL—Alzheimer's disease	1.64e-06	3.81e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—VEGFA—Alzheimer's disease	1.64e-06	3.81e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CCL2—Alzheimer's disease	1.63e-06	3.8e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—IL6—Alzheimer's disease	1.62e-06	3.76e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—AKT1—Alzheimer's disease	1.62e-06	3.76e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.61e-06	3.76e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CASP3—Alzheimer's disease	1.61e-06	3.76e-06	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.61e-06	3.74e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IGF1—Alzheimer's disease	1.6e-06	3.73e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—MAPK8—Alzheimer's disease	1.6e-06	3.72e-06	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—AKT1—Alzheimer's disease	1.6e-06	3.72e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.6e-06	3.72e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CASP3—Alzheimer's disease	1.59e-06	3.71e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—TGFB1—Alzheimer's disease	1.59e-06	3.7e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PPARG—Alzheimer's disease	1.59e-06	3.69e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—IL6—Alzheimer's disease	1.58e-06	3.68e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—IL6—Alzheimer's disease	1.58e-06	3.68e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—IL6—Alzheimer's disease	1.58e-06	3.67e-06	CbGpPWpGaD
Dasatinib—KIT—Disease—AKT1—Alzheimer's disease	1.58e-06	3.67e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—MAPK8—Alzheimer's disease	1.56e-06	3.64e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—INS—Alzheimer's disease	1.56e-06	3.62e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—TGFB1—Alzheimer's disease	1.55e-06	3.61e-06	CbGpPWpGaD
Dasatinib—LYN—Immune System—IL6—Alzheimer's disease	1.54e-06	3.6e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MAPK8—Alzheimer's disease	1.54e-06	3.58e-06	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IL6—Alzheimer's disease	1.54e-06	3.58e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—IL6—Alzheimer's disease	1.53e-06	3.55e-06	CbGpPWpGaD
Dasatinib—FYN—Immune System—IL6—Alzheimer's disease	1.52e-06	3.54e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.51e-06	3.52e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.51e-06	3.52e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TGFB1—Alzheimer's disease	1.5e-06	3.5e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PPARG—Alzheimer's disease	1.5e-06	3.49e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—AKT1—Alzheimer's disease	1.49e-06	3.47e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.48e-06	3.45e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MAPK8—Alzheimer's disease	1.48e-06	3.45e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—MTHFR—Alzheimer's disease	1.48e-06	3.43e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—VEGFA—Alzheimer's disease	1.48e-06	3.43e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—INS—Alzheimer's disease	1.47e-06	3.42e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL6—Alzheimer's disease	1.46e-06	3.41e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MAPK8—Alzheimer's disease	1.46e-06	3.41e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—TP53—Alzheimer's disease	1.46e-06	3.41e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—AKT1—Alzheimer's disease	1.46e-06	3.4e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—AKT1—Alzheimer's disease	1.46e-06	3.4e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—IL6—Alzheimer's disease	1.46e-06	3.39e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—AKT1—Alzheimer's disease	1.46e-06	3.39e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NOS3—Alzheimer's disease	1.45e-06	3.39e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL6—Alzheimer's disease	1.45e-06	3.37e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—VEGFA—Alzheimer's disease	1.44e-06	3.36e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	1.44e-06	3.34e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	1.43e-06	3.33e-06	CbGpPWpGaD
Dasatinib—LYN—Immune System—AKT1—Alzheimer's disease	1.43e-06	3.32e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—VEGFA—Alzheimer's disease	1.42e-06	3.31e-06	CbGpPWpGaD
Dasatinib—ABL1—Immune System—AKT1—Alzheimer's disease	1.42e-06	3.3e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—AKT1—Alzheimer's disease	1.41e-06	3.28e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.41e-06	3.27e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—IL6—Alzheimer's disease	1.4e-06	3.27e-06	CbGpPWpGaD
Dasatinib—FYN—Immune System—AKT1—Alzheimer's disease	1.4e-06	3.27e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CASP3—Alzheimer's disease	1.39e-06	3.25e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CALM1—Alzheimer's disease	1.38e-06	3.21e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—APOE—Alzheimer's disease	1.37e-06	3.2e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—TGFB1—Alzheimer's disease	1.37e-06	3.2e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—VEGFA—Alzheimer's disease	1.37e-06	3.19e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—NOS3—Alzheimer's disease	1.36e-06	3.17e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CAV1—Alzheimer's disease	1.36e-06	3.17e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TGFB1—Alzheimer's disease	1.35e-06	3.15e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—VEGFA—Alzheimer's disease	1.35e-06	3.15e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—AKT1—Alzheimer's disease	1.35e-06	3.14e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—AKT1—Alzheimer's disease	1.34e-06	3.13e-06	CbGpPWpGaD
Dasatinib—MAPK14—Gene Expression—AKT1—Alzheimer's disease	1.34e-06	3.13e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—IL6—Alzheimer's disease	1.34e-06	3.12e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—IL6—Alzheimer's disease	1.33e-06	3.11e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—AKT1—Alzheimer's disease	1.33e-06	3.1e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.33e-06	3.09e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TGFB1—Alzheimer's disease	1.33e-06	3.09e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—LPL—Alzheimer's disease	1.31e-06	3.05e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—TP53—Alzheimer's disease	1.31e-06	3.04e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TGFB1—Alzheimer's disease	1.3e-06	3.04e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—AKT1—Alzheimer's disease	1.3e-06	3.02e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—NOS3—Alzheimer's disease	1.29e-06	3e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.29e-06	3e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MAPK8—Alzheimer's disease	1.28e-06	2.98e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL6—Alzheimer's disease	1.27e-06	2.95e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TGFB1—Alzheimer's disease	1.26e-06	2.92e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	1.25e-06	2.9e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TGFB1—Alzheimer's disease	1.24e-06	2.89e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TP53—Alzheimer's disease	1.24e-06	2.88e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—AKT1—Alzheimer's disease	1.24e-06	2.88e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CASP3—Alzheimer's disease	1.23e-06	2.87e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—AKT1—Alzheimer's disease	1.23e-06	2.87e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.2e-06	2.79e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—IL6—Alzheimer's disease	1.2e-06	2.78e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—VEGFA—Alzheimer's disease	1.18e-06	2.76e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PTGS2—Alzheimer's disease	1.18e-06	2.74e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.18e-06	2.74e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—INS—Alzheimer's disease	1.17e-06	2.73e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—IL6—Alzheimer's disease	1.17e-06	2.72e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—AKT1—Alzheimer's disease	1.17e-06	2.72e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MAPK8—Alzheimer's disease	1.13e-06	2.64e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—IL6—Alzheimer's disease	1.13e-06	2.64e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL6—Alzheimer's disease	1.12e-06	2.61e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TP53—Alzheimer's disease	1.11e-06	2.59e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.11e-06	2.58e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.1e-06	2.57e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—AKT1—Alzheimer's disease	1.1e-06	2.57e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.1e-06	2.56e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.1e-06	2.55e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TP53—Alzheimer's disease	1.09e-06	2.54e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.09e-06	2.53e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TGFB1—Alzheimer's disease	1.09e-06	2.53e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—AKT1—Alzheimer's disease	1.08e-06	2.51e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TP53—Alzheimer's disease	1.07e-06	2.5e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—VEGFA—Alzheimer's disease	1.05e-06	2.44e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—AKT1—Alzheimer's disease	1.04e-06	2.43e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—IL6—Alzheimer's disease	1.03e-06	2.41e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TP53—Alzheimer's disease	1.03e-06	2.41e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—AKT1—Alzheimer's disease	1.03e-06	2.41e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.03e-06	2.4e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TP53—Alzheimer's disease	1.02e-06	2.38e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—IL6—Alzheimer's disease	1.02e-06	2.37e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.01e-06	2.35e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—IL6—Alzheimer's disease	9.99e-07	2.32e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IL6—Alzheimer's disease	9.83e-07	2.29e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TGFB1—Alzheimer's disease	9.62e-07	2.24e-06	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—AKT1—Alzheimer's disease	9.62e-07	2.24e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PPARG—Alzheimer's disease	9.55e-07	2.22e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—AKT1—Alzheimer's disease	9.55e-07	2.22e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IL6—Alzheimer's disease	9.47e-07	2.2e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PTGS2—Alzheimer's disease	9.41e-07	2.19e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—AKT1—Alzheimer's disease	9.41e-07	2.19e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—INS—Alzheimer's disease	9.37e-07	2.18e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IL6—Alzheimer's disease	9.35e-07	2.18e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—AKT1—Alzheimer's disease	9.21e-07	2.14e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	9.09e-07	2.12e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—AKT1—Alzheimer's disease	9.07e-07	2.11e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TP53—Alzheimer's disease	8.94e-07	2.08e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—AKT1—Alzheimer's disease	8.75e-07	2.04e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—AKT1—Alzheimer's disease	8.74e-07	2.03e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—AKT1—Alzheimer's disease	8.62e-07	2.01e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CALM1—Alzheimer's disease	8.49e-07	1.98e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—APOE—Alzheimer's disease	8.46e-07	1.97e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CAV1—Alzheimer's disease	8.39e-07	1.95e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—NOS3—Alzheimer's disease	8.22e-07	1.91e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL6—Alzheimer's disease	8.19e-07	1.91e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TP53—Alzheimer's disease	7.92e-07	1.84e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—AKT1—Alzheimer's disease	7.55e-07	1.76e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	7.51e-07	1.75e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PPARG—Alzheimer's disease	7.37e-07	1.72e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL6—Alzheimer's disease	7.25e-07	1.69e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—INS—Alzheimer's disease	7.23e-07	1.68e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—AKT1—Alzheimer's disease	6.69e-07	1.56e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—NOS3—Alzheimer's disease	6.34e-07	1.48e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—AKT1—Alzheimer's disease	6.27e-07	1.46e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—AKT1—Alzheimer's disease	5.92e-07	1.38e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	5.8e-07	1.35e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—AKT1—Alzheimer's disease	4.73e-07	1.1e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—AKT1—Alzheimer's disease	3.78e-07	8.79e-07	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—AKT1—Alzheimer's disease	2.91e-07	6.78e-07	CbGpPWpGaD
